NCT01339468View on ClinicalTrials.gov

A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 27, 2011

Primary Completion Date

May 27, 2014

Study Completion Date

May 27, 2014

Conditions
Liver Transplantation
Interventions
DRUG

Advagraf

oral

DRUG

Prograf

oral

DRUG

Prograf

intravenous

Trial Locations (1)

Unknown

Seoul

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01339468 - A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation | Biotech Hunter | Biotech Hunter